Provided by Tiger Fintech (Singapore) Pte. Ltd.

OncoCyte Corporation

3.20
0.0000
Volume:- -
Turnover:318.43K
Market Cap:91.52M
PE:-0.96
High:3.20
Open:3.20
Low:3.20
Close:3.20
52wk High:4.75
52wk Low:1.92
Shares:28.60M
Float Shares:7.76M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3429
EPS(LYR):-4.6612
ROE:-428.96%
ROA:-22.17%
PB:8.96
PE(LYR):-0.69

Loading ...

Lake Street Keeps Their Buy Rating on OncoCyte (OCX)

TIPRANKS
·
Jun 17

BRIEF-Oncocyte Changes Name To Insight Molecular Diagnostics

Reuters
·
Jun 17

OncoCyte Corporation Relocates Headquarters to Nashville, Rebrands as Insight Molecular Diagnostics

Reuters
·
Jun 17

OncoCyte Changes Name to Insight Molecular Diagnostics Inc. (Imdx), Moves Headquarters to Nashville

THOMSON REUTERS
·
Jun 17

Oncocyte Is Maintained at Buy by Lake Street

Dow Jones
·
May 22

OncoCyte reports Medicare boosts reimbursement for GraftAssureCore

TIPRANKS
·
May 21

BRIEF-Oncocyte Corp Says New CMS Reimbursement Price Rate Of $2,753 Per Result For Graftassurecore Assay

Reuters
·
May 20

OncoCyte Corp - New CMS Reimbursement Price Rate of $2,753 per Result for Graftassurecore Assay

THOMSON REUTERS
·
May 20

OncoCyte Corporation Releases Transcript for Q1 2025 Earnings Call

Reuters
·
May 15

Oncocyte Price Target Maintained With a $4.25/Share by Needham

Dow Jones
·
May 13

OncoCyte Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

OncoCyte Q1 Adj. EPS $(0.19) Beats $(0.23) Estimate, Sales $2.32M Beat $154.50K Estimate

Benzinga
·
May 13

OncoCyte Reports Q1 2025 Results and Business Progress

THOMSON REUTERS
·
May 13

OncoCyte Corp: Plan to Rename Company in Q2

THOMSON REUTERS
·
May 13

OncoCyte Corp expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
May 10

BRIEF-Oncocyte Provides Positive Update On Clinical Trial ProgresS

Reuters
·
Apr 30

OncoCyte Provides Positive Update on Clinical Trial Progress

THOMSON REUTERS
·
Apr 30

Oncocyte Provides Positive Update on Clinical Trial Progress

GlobeNewswire
·
Apr 30

Oncocyte’s Proprietary Assay Demonstrates Long-Term Clinical Validity

GlobeNewswire
·
Apr 29

STAAR Surgical Announces Changes to Board of Directors

Business Wire
·
Apr 25